Infectious Disease
Rare Events of ITPÂ Associated With ChAdOx1 Vaccine
Small increased risk for idiopathic thrombocytopenic purpura seen after first dose with estimated incidence of 1.13 cases per 100,000 doses
Obesity Tied to Long-Term COVID-19 Complications
Increases seen for hospital admission, mortality, need for diagnostic medical tests occurring 30+ days after positive COVID-19 test
16.3 Percent of Pregnant Women Have Had COVID-19 Vaccine
Receipt of vaccine highest for women aged 35 to 49 years and for Asian and White versus Hispanic and Black women
U.S. Supreme Court Strikes Down Challenge to Affordable Care Act
Ruling did not address whether the Obama-era law can continue without a provision that requires Americans obtain insurance or pay a penalty
Ahead of Tokyo Olympics, Japan Eases COVID-19 Restrictions
Experts say it is crucial to accelerate the vaccine rollout for the Olympics to be safe
CureVac’s COVID-19 Vaccine Only 47 Percent Effective
Vaccine's efficacy is the lowest reported so far by a COVID-19 vaccine maker
U.S. Buys 200 Million Extra Moderna Vaccine Doses, as Possible Booster Shots
It is not clear yet whether, or when, booster shots might be necessary
Disparities in COVID-19 Vaccination ID’d Among Health Employees
At MetroHealth System, probability of vaccination up for employees older than 44 years, men, Whites, and Asians
Modifiable Cardiovascular Risk Factors Linked to Severity of COVID-19
Strategies that improve cardiovascular health may also improve outcomes for people following COVID-19
Coronavirus Delta Variant Classified ‘Variant of Concern’ by CDC
The variant, also known as B.1.617.2, was identified in India in December and had been detected in 54 countries by June
